SILK - Silk Road Medical Inc. (SILK) Investigation: Bronstein Gewirtz & Grossman LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK, NY / ACCESSWIRE / October 26, 2023 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Silk Road Medical, Inc. ("SilkRoad" or "the Company") (NASDAQ:SILK). Investors who purchased SilkRoad securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/silk.

The investigation concerns whether SilkRoad has violated federal securities laws.

Investigation Details:

On October 10, 2023, Silk Road announced that its second quarter 2023 revenues were expected to be below its first quarter revenues and significantly reduced its expected full year 2023 revenues. Concurrently, Silk Road announced the departure of Chief Executive Officer Erica Rogers. Although Silk Road did not offer any explanation for its reduced revenues, the announcement followed the Centers for Medicare & Medicaid Services' July 2023 proposed National Coverage Determination, which reportedly proposed to change coverage for a stroke treatment for carotid artery disease that could put a competing therapy alongside Silk Road's Transcarotid Artery Revascularization therapy regarding reimbursement. On this news, Silk Road's stock price fell $6.86 per share, or 49.04%, to close at $7.13 per share on October 11, 2023.

What's Next?

If you are aware of any facts relating to this investigation or purchased SilkRoad securities, you can assist this investigation by visiting the firm's site: bgandg.com/silk . You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman:

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC